Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy
  • Project pages
    • MDR & IVDR
    • Innovation & Startups

Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 13/08/2024

    Peptide Boronic Acids: New Prospects for Immunology

    A cutting-edge chemical process is the first to make it possible to quickly and easily produce modified peptides with boronic acids. As part of this work, scientists managed to synthesize a large number of different biologically active peptide boronic acids and investigate their properties. They open up new possibilities in the young research field of synthetic immunology and could go on to be used primarily in immunotherapy.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/peptide-boronic-acids-new-prospects-immunology
  • Start-up Cerebri GmbH - 05/08/2024 Cerebri-logo.png

    Comprehensive EEG supply thanks to telemedicine

    Fewer and fewer patients are getting timely access to electroencephalograms, as the process of measuring brain activity and interpreting the results requires specific expertise. Cerebri GmbH, a newly established Tübingen-based company, aims to address this issue by offering user-friendly EEG caps and providing rapid, location-independent and top-tier diagnostics by experts.

    https://biopro-v9-test-gi.xanium.io/en/article/news/comprehensive-eeg-supply-thanks-telemedicine
  • Press release - 01/08/2024

    Targeted therapy for cancer of unknown primary (Cup)

    Encouraging results from a large international study led by Heidelberg have recently been published in the journal “Lancet”: The genetic material of cancer cells with unknown tissue of origin contains numerous targets for specific drugs that are already available and have been developed to treat other forms of cancer. These suppressed the disease in CUP patients for significantly longer than chemotherapy.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/targeted-therapy-cancer-unknown-primary-cup
  • Research association - 24/07/2024 Graphic in which the various thematic lines of the performance centre are shown in a circle using symbols, e.g. the health thematic line as a heart with a graph of an ECG measurement.

    SPI-MP: pioneer in personalised medical technology

    Every person is unique – even when they are ill. This is why many approaches to personalised medicine have been under development. The Stuttgart Partnership Initiative - Mass Personalization (SPI-MP), which focuses on basic research into fabrication and biomaterial technologies for personalised biomedical systems, is at the heart of such research work. The projects range from artificial knee joint cartilage to state-of-the-art stroke diagnostics.

    https://biopro-v9-test-gi.xanium.io/en/article/news/spi-mp-pioneer-personalised-medical-technology
  • Press release - 10/07/2024

    HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration

    HepaRegeniX GmbH, a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic liver diseases, announced the closing of a Series C round led by Vesalius Biocapital IV with participation of existing investors Novo Holdings, Boehringer Ingelheim Venture Fund (BIVF), and High-Tech Gründerfonds. The new funds of €15 million will be used to advance the clinical development of the clinical candidate HRX-215.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/heparegenix-raises-euro-15-million-series-c-round-advance-clinical-development-hrx-215-liver-regeneration
  • TWYCE GmbH - 10/07/2024 A micrograph shows how two T cells attack two tumour cells.

    Better immune response against prostate cancer thanks to new bispecific antibodies

    TWYCE, a Tübingen-based start-up spun off from the German Cancer Research Center in Heidelberg and the Faculty of Medicine at the University of Tübingen, is focused on developing a combinatorial therapy using two bispecific antibodies from bench to clinical practice. The founders aim to introduce an effective strategy for combating solid tumours, with initial proof of concept targeted at prostate cancer.

    https://biopro-v9-test-gi.xanium.io/en/article/news/better-immune-response-against-prostate-cancer-thanks-new-bispecific-antibodies
  • Press release - 05/07/2024

    Outstanding ideas – new imaging processes for cancer diagnostics and nanopropellers for ocular gene therapy

    The summer reception hosted by BioRegio STERN Management GmbH has once again provided a fitting backdrop for the Science2Start award ceremony. Last Thursday, at Tübingen observatory, was the 15th time that scientists and start-up founders were celebrated for outstanding ideas that a panel of experts judged to have special economic potential.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/outstanding-ideas-new-imaging-processes-cancer-diagnostics-and-nanopropellers-ocular-gene-therapy
  • Press release - 03/07/2024

    Advancement Award for Heidelberg Molecular Biologist

    For her ground-breaking scientific studies in the field of synthetic biology, the 2024 Alfried Krupp Advancement Award is to go to Prof. Dr Kerstin Göpfrich. The award, endowed with one million euros in funding, is granted annually by the Alfried Krupp von Bohlen und Halbach Foundation to young academics holding their first professorship in the natural and engineering sciences.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/advancement-award-heidelberg-molecular-biologist
  • Press release - 02/07/2024

    Faster use of new technologies in rehabilitation

    BioRegio STERN Management GmbH is a partner in the new RehAllianCE project, which is being funded by the EU as part of the Interreg CENTRAL EUROPE program. The focus is on the use of new technologies in rehabilitation to improve patient care. The aim is to increase the innovation capacities of SMEs so that aids such as rehabilitation robots, exoskeletons etc. can be used more quickly.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/faster-use-new-technologies-rehabilitation
  • Press release - 02/07/2024

    DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier

    Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics today announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor classification.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/dkfz-spin-epignostix-raises-euro-43m-seed-round-commercialize-diagnostic-tumor-classifier
  • Baden-Württemberg receives the EU Commission's "Regional Innovation Valley" label - 01/07/2024 BIOPRO_logo.jpg

    Customised healthcare for all: BIOPRO is a partner in the EU project PRECISEU

    The EU research project PRECISEU, which started in June 2024 and will run for five years, aims to connect innovation ecosystems across Europe and advance personalised medicine throughout Europe. BIOPRO Baden-Württemberg is one of 25 partner organisations from 11 European countries that are working on the further development of customised healthcare as part of the research project.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/customised-healthcare-all-biopro-partner-eu-project-preciseu
  • Press release - 24/06/2024

    Trustworthy AI Made in Mannheim

    How can we use artificial intelligence (AI) to make comprehensible medical decisions? A new project at the University of Mannheim, which has received funding from the Federal Ministry of Education and Research (BMBF), will analyze this question.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/trustworthy-ai-made-mannheim
  • Press release - 21/06/2024

    Cyber Valley: World's first ELLIS Institute opens

    At the finale of the Cyber Valley Days, and Science Minister Petra Olschowski opened the ELLIS Institute Tübingen, heralding the next phase of the AI Innovation Campus. With the world's first ELLIS Institute, Cyber Valley is gaining further radiance. Olschowski also announced at the ceremony that the Karlsruhe Institute of Technology (KIT) is joining the Cyber Valley Community.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/cyber-valley-worlds-first-ellis-institute-opens
  • Press release - 13/06/2024

    BioRegio STERN receives 2024 award for best ZIM innovation network

    BioRegio STERN Management GmbH was today presented with an award at the Innovation Day for SMEs held by Germany’s Federal Ministry for Economic Affairs and Climate Action. Its “biohymed” project was named the year’s best innovation network under the Central Innovation Programme for SMEs (ZIM).

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/bioregio-stern-receives-2024-award-best-zim-innovation-network
  • Press release - 05/06/2024

    Investing in a fairer future: The Robert Bosch Stiftung celebrates its 60th anniversary

    he Robert Bosch Stiftung is celebrating its 60th anniversary in 2024. To commemorate this, the Foundation is holding an anniversary celebration today at its headquarters in Stuttgart. Among the guests are partners from the Foundation's charitable work as well as representatives from politics, business, and society, including members of the Bosch family and company.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/investing-fairer-future-robert-bosch-stiftung-celebrates-its-60th-anniversary
  • Press release - 31/05/2024

    Heidelberg University successful with six bids for collaborative research

    In the current approval round of the German Research Foundation (DFG) Heidelberg University has been successful with six applications for grants to fund major, internationally visible research consortia. The six research consortia − three of them will reach the maximum funding length of twelve years after their extension − are to receive financial resources totalling nearly 87 million euros over a period of four years.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/heidelberg-university-successful-six-bids-collaborative-research
  • Press release - 24/05/2024

    Research Training Group on Cancer Surgery: German Research Foundation approves second funding period

    Since 2019, the Research Training Group (RTG) "Intraoperative Multisensoric Tissue Differentiation in Oncology," a collaboration between the University of Stuttgart and the University of Tübingen, has been advancing research in medical technology. With the help of new sensor methods, the researchers want to help make surgical procedures on cancer patients safer and more effective.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/research-training-group-cancer-surgery-german-research-foundation-approves-second-funding-period
  • Press release - 23/05/2024

    "They heal wounds, allow bones to grow and calm inflammation" MWK funds cell therapy research into mesenchymal stromal cells with 600,000 euros

    The Baden-Württemberg Ministry of Science, Research and Arts (MWK) is supporting medical researchers at Ulm University with start-up funding totalling 600,000 euros. The aim is to establish an EU consortium for the broad therapeutic use of mesenchymal stromal cells. The funding is being awarded as part of the "BEGIN - Participation in major European projects and initiatives" programme.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/they-heal-wounds-allow-bones-grow-and-calm-inflammation-mwk-funds-cell-therapy-research-mesenchymal-stromal-cells-600000-euros
  • Press release - 22/05/2024

    Stretched beyond the limits of the cell: the molecular biomechanics of collagen

    Together with colleagues from Israel and USA, HITS researcher Frauke Gräter investigates the effects of physical force on the collagen protein in two different animal model systems. Their goal is to measure the effects of mechanoradicals on the integrity of the tissue and the well-being of the organism, with impact on health and aging.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/stretched-beyond-limits-cell-molecular-biomechanics-collagen
  • Press release - 13/05/2024

    Detecting respiratory infections: simply blow for diagnosis

    Professor Claudia Denkinger from Heidelberg University's Faculty of Medicine is leading the international collaborative project "BreathForDiagnosis". Researchers from Germany, Italy, South Africa and Romania are working with an industrial partner from Switzerland to develop user-friendly breath tests for the rapid diagnosis of respiratory infections such as tuberculosis.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/detecting-respiratory-infections-simply-blow-diagnosis
  • Press release - 18/04/2024

    Collagen: Researchers at the NMI decipher how it works in medical treatment

    Collagen has been used in ophthalmology since the 1990s, particularly in the treatment of corneal defects. However, why and how this technique works was only known in theory. Researchers at the NMI Natural and Medical Sciences Institute in Reutlingen led by Lu Fan have found the necessary evidence and can now reliably explain how this technique works.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/collagen-researchers-nmi-decipher-how-it-works-medical-treatment
  • Press release - 10/04/2024

    Cyber Valley grants 500K to CELL’n’ROLL via 2023 Innovation Fellowship Program

    Pioneering cutting-edge diagnostic systems for the detection of complex diseases: Cyber Valley is pleased to announce it has awarded funding of 500K EUR to the CELL’n’ROLL team through the 2023 Cyber Valley Innovation Fellowship program, funded by the Carl-Zeiss-Stiftung.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/cyber-valley-grants-500k-cellnroll-2023-innovation-fellowship-program
  • Press release - 22/03/2024

    New Emmy Noether junior research group for biological data science

    An Emmy Noether junior research group at Heidelberg University is investigating how to gain new insights into fundamental biological mechanisms from large-scale molecular data sets. Led by Junior Professor Dr Britta Velten, it has started work at the Centre for Organismal Studies and the Interdisciplinary Center for Scientific Computing.

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/new-emmy-noether-junior-research-group-biological-data-science
  • Press release - 05/03/2024

    New Center for Synthetic Genomics

    Applying and developing new technologies for DNA synthesis to pave the way for producing entire artificial genomes – that is the goal of a new interdisciplinary center, 'Center for Synthetic Genomics', that is being established at Heidelberg University, Karlsruhe Institute of Technology (KIT), and Johannes Gutenberg University Mainz (JGU).

    https://biopro-v9-test-gi.xanium.io/en/article/press-release/new-center-synthetic-genomics
  • Press release - 12/02/2024

    AI-supported image analysis: metrics determine quality

    How well do the algorithms used in the AI-supported analysis of medical images perform their tasks? This depends to a large extent on the metrics used to evaluate their performance. An international consortium led by scientists from the German Cancer Research Center and the National Center for Tumor Diseases has compiled the knowledge available worldwide on the specific strengths, weaknesses and limitations of the various validation metrics.

    https://biopro-v9-test-gi.xanium.io/en/article/news/ai-supported-image-analysis-metrics-determine-quality

Page 1 / 6

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2025
Website address: https://biopro-v9-test-gi.xanium.io/en/search